LSE Leishen ongoing renewable capacity expansions lift core operating outlook for the full fiscal year Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia Is Arbor Pref E ABRE stock stronger than peers ABRE Recent Quarter Earnings Arbor Pref E posts no EPS revenue 625 dividend holds steady